Clinical trials

8

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia

Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: FemaleType: InterventionalSponsor: Applied Biology, Inc.Updated: Apr 13, 2026Locations: 2
Eligibility criteria

Diagnosed with stage I or stage II breast cancer [+3]

Resting blood pressure outside the range of 105-140/ 55-99 [+9]

Status: Not yet recruiting

Pharmacokinetic Study of DA-020

Pharmacokinetic Study of DA-020

Participants needed: 60
Trial details
Phase: Early Phase 1Age: 18-55Biological sex: FemaleType: InterventionalSponsor: Applied Biology, Inc.Updated: Apr 13, 2026Locations: 2
Eligibility criteria

Healthy females, age 18-55 [+4]

History of cardiovascular disease, hypertension, or arrhythmia [+4]

Status: Not yet recruiting

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

The primary objective of the study is to assess the safety and efficacy of DA-001 as a treatment for Hair Shedding Reduction and Hair Re-Growth

Participants needed: 1,120
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Apr 13, 2026
Eligibility criteria

Age 18 or older [+4]

A medical history that may interfere with study objectives [+7]

Status: Recruiting

Pharmacokinetic Study of Topical Phenylephrine

Pharmacokinetic Study of Topical Phenylephrine

Participants needed: 24
Trial details
Phase: Early Phase 1Age: 18-55Biological sex: FemaleType: InterventionalSponsor: Applied Biology, Inc.Updated: Oct 3, 2025Locations: 1
Eligibility criteria

Healthy females, age 18-55 [+4]

History of cardiovascular disease, hypertension, or arrhythmia [+4]

Status: Not yet recruiting

Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 30-65Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Sep 10, 2025
Eligibility criteria

Age 30 to 65 [+4]

A medical history that may interfere with study objectives [+7]

Status: Not yet recruiting

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

Clinical Study of DA-007 As a Treatment for Chemotherapy Induced Alopecia

Participants needed: 140
Trial details
Phase: Phase 3Age: 18-65Biological sex: FemaleType: InterventionalSponsor: Applied Biology, Inc.Updated: May 23, 2025Locations: 1
Eligibility criteria

Diagnosed with stage I or stage II breast cancer [+3]

Resting blood pressure outside the range of 105-140/ 55-99 [+9]

Status: Not yet recruiting

Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)

Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)

Participants needed: 240
Trial details
Phase: Phase 3Age: 30-65Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Dec 24, 2024
Eligibility criteria

Age 30 to 65 [+4]

A medical history that may interfere with study objectives [+7]

Status: Not yet recruiting

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

The primary objective of the study is to assess the safety and efficacy of DA-005 and DA-002 as a treatment for hair loss (androgenetic alopecia).

Participants needed: 516
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Applied Biology, Inc.Updated: Dec 19, 2024
Eligibility criteria

Age 18 or older [+4]

A medical history that may interfere with study objectives [+7]